GURU.Markets stock price, segment price, and overall market index valuation
The company's share price DARE
Dare Bioscience is a biopharmaceutical company focused on women's health. Its stock price is driven by news of clinical trials for its broad portfolio of products. The chart is a story of risks and hopes in this important but underfunded field.
Share prices of companies in the market segment - Pharma women
Dare Bioscience is a pharmaceutical company focused exclusively on developing treatments to improve women's health, from contraception to infection treatment. We've classified it as a "Women's Pharmaceutical." The chart below shows the dynamics in this important and underserved sector.
Broad Market Index - GURU.Markets
Daré Bioscience is a biopharmaceutical company focused on developing innovative treatments for women's health, including contraception and infection treatment. It is a component of the GURU.Markets index, and the chart below shows how its stock compares to the broader market.
Change in the price of a company, segment, and market as a whole per day
DARE - Daily change in the company's share price DARE
For Daré Bioscience, Inc., a company focused on women's health, daily volatility reflects sensitivity to FDA decisions. This metric is key to assessing the company's risk as it develops innovative contraceptives and medications.
Daily change in the price of a set of shares in a market segment - Pharma women
Daré Bioscience, Inc. is a pharmaceutical company. This chart highlights the sector's high volatility. Comparing it to DARE, which focuses on women's health, helps us assess it as a high-risk, clinical-data-driven asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Daré Bioscience is a pharmaceutical company focused on women's health. Its shares are highly volatile and dependent on clinical trial results. These scientifically based movements are part of the complex picture of the overall stock market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization DARE
Daré Bioscience's year-over-year performance tells the story of its focus on women's health. Its 12-month market cap growth reflects its success in securing FDA approval for its first product, a gel for bacterial vaginosis, as well as progress in developing its portfolio of other innovative products, including contraceptives.
Annual dynamics of market capitalization of the market segment - Pharma women
Daré Bioscience, Inc. is a biopharmaceutical company with a unique focus on women's health. Its diversified pipeline of candidates is a key advantage. The chart shows how its clinical development success and focus on this underserved market are driving its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Dare, specializing in women's health, operates in the defensive sector. Its stock price is not dependent on the economy, but rather on the success of its clinical trials and regulatory approvals. The chart tells the story of how the biotech company is trying to find solutions for an underserved market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization DARE
Dare Bioscience is a biopharmaceutical company focused on women's health. Its monthly performance is driven by progress in its extensive clinical pipeline. News of FDA approvals for its leading drugs is the main driver of its valuation.
Monthly dynamics of market capitalization of the market segment - Pharma women
Dare Bioscience is a pharmaceutical company focused exclusively on women's health. This is a large but often underserved area of medicine. The dynamics of the pharmaceutical sector provide the backdrop against which Dare strives to bring new products to market for contraception, treatment of infections, and other conditions, solving important problems for millions of women.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Dare Bioscience, Inc. is a biopharmaceutical company focused exclusively on developing innovative products for women's health. The company's future depends on the success of its clinical trials and regulatory approvals. The broader market chart serves only as a backdrop to understand how its unique mission and development pipeline have impacted its stock price.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization DARE
Daré Bioscience is a biopharmaceutical company focused on women's health. Its weekly stock price is volatile and depends on news about clinical trials of its products, FDA decisions, and licensing agreements with major pharmaceutical companies.
Weekly dynamics of market capitalization of the market segment - Pharma women
Daré Bioscience is a biopharmaceutical company focused on women's health. Its weekly stock price is volatile and depends on news about clinical trials of its products, FDA decisions, and licensing agreements with major pharmaceutical companies.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Shares of Daré, a biotech company, live in a world of their own. Their performance is driven by clinical trial data. A chart comparing the stock to the S&P 500 clearly demonstrates how the stock can rise or fall, completely ignoring the broader market.
Market capitalization of the company, segment and market as a whole
DARE - Market capitalization of the company DARE
Daré Bioscience's market capitalization tells the story of a biotech company focused on women's health. Its chart reflects the promise and risks of developing a product portfolio, from contraceptives to infection treatments. It's a visualization of how the market values this important, yet often overlooked, area of pharmaceuticals.
DARE - Share of the company's market capitalization DARE within the market segment - Pharma women
Daré Bioscience is a biopharmaceutical company focused exclusively on developing women's health products. Its market capitalization reflects its leadership in this underserved niche. The chart below shows how its market share reflects the progress of its broad pipeline.
Market capitalization of the market segment - Pharma women
Dare Bioscience is a biopharmaceutical company focused exclusively on women's health. The chart below shows the overall market capitalization of the women's health pharmaceuticals sector. It reflects the growing attention to this previously underserved area of medicine and the potential for new products.
Market capitalization of all companies included in a broad market index - GURU.Markets
Women's health is shown here. Dare Bioscience is developing a portfolio of drugs for women's health, from contraception to vaginal infections. Its line on the graph reflects progress in clinical trials in this often underfunded but vast field of medicine.
Book value capitalization of the company, segment and market as a whole
DARE - Book value capitalization of the company DARE
Daré Bioscience's foundation is its pipeline of women's health drugs, from contraception to treatments for vaginal infections. This represents focused scientific capital. This chart shows how the biotech company manages its budget to advance its many products through clinical trials in this important but often overlooked area of medicine.
DARE - Share of the company's book capitalization DARE within the market segment - Pharma women
Dare Bioscience is a biopharmaceutical company focused on women's health. Its assets are intellectual property. The chart shows a minimal share of physical assets, as it is an R&D company.
Market segment balance sheet capitalization - Pharma women
Women's health drug development, as the BCap_Ges biotech chart shows, is a science-intensive industry. Daré Bioscience operates in this environment, where capital is invested in clinical research rather than plant construction.
Book value of all companies included in the broad market index - GURU.Markets
Daré Bioscience's assets are capital dedicated to the development and commercialization of women's health products. This book value provides the financial foundation that enables the company to bring real, tangible drugs and devices to market, from contraceptives to infection treatments.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - DARE
Dare Bioscience is a pharmaceutical company focused on women's health, an often undervalued niche. Market capitalization is a measure of its development pipeline. The MvsBCap chart will reflect clinical trial progress and the potential market size for its unique products.
Market to book capitalization ratio in a market segment - Pharma women
Daré Bioscience is a biopharmaceutical company focused on women's health. Its value depends on the success of its development pipeline. The chart shows how investors assess its potential in this important and often neglected area of medicine.
Market to book capitalization ratio for the market as a whole
Dare Bioscience specializes in developing women's health products, an important yet often overlooked area of pharmaceuticals. The company's market valuation reflects the potential of its products to address unmet medical needs for women, rather than its current tangible assets.
Debts of the company, segment and market as a whole
DARE - Company debts DARE
Dare Bioscience, a biopharmaceutical company focused on women's health, is devoting all its capital to clinical trials of its pipeline of drug candidates. This underfunded area of medicine requires innovation. This chart shows how the company is managing its resources on the long and risky path to developing new products for women.
Market segment debts - Pharma women
Daré Bioscience is a biopharmaceutical company focused on developing products for women's health. This important, yet often underfunded, area of medicine requires innovation. The chart shows how Daré is raising capital to fund its clinical research and bring new therapeutic solutions to market for women.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio DARE
Dare Bioscience focuses on developing women's health products, an underfunded area in the pharmaceutical industry. This chart shows its reliance on debt to conduct clinical trials. Its high debt is a bet that its innovative products will be in demand and find their niche in the market.
Market segment debt to market segment book capitalization - Pharma women
Dare Bioscience is a biopharmaceutical company focused exclusively on women's health. The chart shows the sector's debt load. It helps understand how the company finances the development of its product portfolio in various, often underserved areas of women's health, and how its strategy compares to other niche pharma companies.
Debt to book value of all companies in the market
Dare Bioscience, Inc. is a biopharmaceutical company focused on developing innovative products for women's health. This chart, showing overall capital availability, is critical for the company. Funding clinical trials and bringing new drugs to market in this important, yet often underfunded, area depends on the health of financial markets.
P/E of the company, segment and market as a whole
P/E - DARE
This chart from Dare Bioscience, a company focused on women's health, shows how investors value its development pipeline. The dynamics reflect expectations for approval and commercial success of its products, from contraceptives to infection treatments, which could address important unmet needs.
P/E of the market segment - Pharma women
This chart shows the average P/E valuation for the pharmaceutical industry, where Dare Bioscience specializes in women's health. This metric serves as a benchmark for how the market views the potential of the company's drug portfolio relative to other developments in this important niche.
P/E of the market as a whole
Dare Bioscience is a biopharmaceutical company focused on developing women's health products, such as contraceptives and infection treatments. This chart shows the biotech sentiment. It helps understand how the market views the potential of this often undervalued pharmaceutical segment and Dare's chances of commercializing its diverse product portfolio.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company DARE
Dare Bioscience is a biopharmaceutical company focused exclusively on developing women's health products, from contraception to infection treatments. This chart demonstrates analysts' confidence in the company's ability to successfully launch its products and achieve leadership in this important, yet often overlooked, niche.
%20P%2FE%20DARE&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-DARE&v=1772582746086 "Chart of the company's future (projected) P/E DARE")
Future (projected) P/E of the market segment - Pharma women
Daré Bioscience is a biopharmaceutical company focused on developing innovative products for women's health, including contraception and treatment of vaginal infections. This chart shows how its future revenue expectations compare to the industry average, reflecting the potential of its products in this important and often neglected area.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20women&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-women&v=1772582746167 "Future (projected) P/E graph of the market segment - Pharma women")
Future (projected) P/E of the market as a whole
Dare Bioscience is a pharmaceutical company focused on women's health, an important yet often undervalued area of medicine. This chart, showing the overall market appetite for risk, impacts capital availability for all biotech companies. Investor optimism helps Dare fund the development and launch of new products.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772582746275 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit DARE
Dare Bioscience, Inc. is a biopharmaceutical company focused exclusively on women's health. The company's revenue target is contingent on the approval and commercialization of its drug portfolio. This chart shows how much it invests in developing products to address unmet needs in women's health.
Profit of companies in the market segment - Pharma women
Dare Bioscience is a biopharmaceutical company focused exclusively on developing women's health products, from contraception to infection treatment. This chart illustrates a common dynamic in the pharmaceutical industry, where focusing on underserved areas like women's health can create a strong market niche and drive sustainable growth.
Overall market profit
Dare Bioscience specializes in women's health products. The demand for such products is driven by medical factors, not economics. However, the company's ability to finance its development depends on the overall investment climate, which is closely linked to the corporate profit dynamics shown in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company DARE
Daré Bioscience is a biopharmaceutical company focused exclusively on women's health. It is developing a portfolio of drugs for contraception, infections, and other conditions. This chart shows how analysts assess the commercial potential of its unique portfolio and future profitability.
%20profit%20of%20the%20company%20DARE&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-DARE&v=1772582746449 "Graph of future (projected) profit of the company DARE")
Future (predicted) profit of companies in the market segment - Pharma women
Daré Bioscience is a biopharmaceutical company focused exclusively on developing innovative products for women's health, including contraception, vaginal health, and sexual health. This chart shows profitability projections for the pharmaceutical sector. It reflects the growing attention and need for new therapeutic solutions in this historically underfunded area.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20women&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-women&v=1772582746483 "Graph of future (predicted) profits of companies in a market segment - Pharma women")
Future (predicted) profit of the market as a whole
Dare Bioscience, Inc. specializes in developing women's health products. This is an important, yet often underfunded, area of pharmaceuticals. This chart, reflecting overall market sentiment, impacts the availability of capital for biotech companies working in niche but socially significant areas of medicine.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772582746497 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - DARE
Daré Bioscience is a biopharmaceutical company focused on women's health. This chart shows the valuation of its development pipeline. The high valuation reflects not current sales, but the potential of its products to address unmet medical needs for women.
P/S market segment - Pharma women
Daré Bioscience, Inc. is a biopharmaceutical company focused on developing innovative products for women's health. This chart shows the average revenue estimate in the biotech sector. It helps understand how investors value Daré's portfolio of products targeting unmet needs in contraception and women's sexual health.
P/S of the market as a whole
Dare Bioscience is a biopharmaceutical company focused exclusively on developing women's health products, from contraception to infection treatments. They operate in an underserved but large niche. This chart provides a general revenue metric against which to judge how the market values biotech companies focused on women's health.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company DARE
Daré Bioscience is a biopharmaceutical company focused exclusively on developing women's health products, such as contraceptives and infection treatments. This chart reflects investor expectations for its portfolio. The valuation is based on the potential of its candidates to address unmet needs in this important area of medicine.
%20P%2FS%20DARE&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-DARE&v=1772582746709 "The graph of the company's future (projected) P/S DARE")
Future (projected) P/S of the market segment - Pharma women
Daré Bioscience is a biopharmaceutical company specializing in the development of innovative women's health products, including contraceptives and treatments for infections. This chart shows how the market values its portfolio of drugs in an important but often overlooked area.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20women&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-women&v=1772582746800 "Future (projected) P/S market segment graph - Pharma women")
Future (projected) P/S of the market as a whole
Dare Bioscience is a biopharmaceutical company focused on women's health. This chart, reflecting the overall investment climate, is important for the company. Market optimism facilitates the funding Dare needs to conduct clinical trials and bring new products to market in this important, yet often underfunded, area of medicine.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772582746900 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales DARE
Dare Bioscience is a biopharmaceutical company focused exclusively on developing treatments for women's health. This chart reflects revenue, which may come from licensing agreements, grants, or initial sales of its products. It demonstrates progress in addressing previously neglected medical issues facing women.
Sales of companies in the market segment - Pharma women
Dare Bioscience, Inc. is a biopharmaceutical company focused entirely on advancing innovative products for women's health. Its business consists of a portfolio of various drug candidates, each of which represents a distinct segment targeting a specific problem. This chart shows the financial flows associated with one of them.
Overall market sales
Dare Bioscience, Inc. is a biopharmaceutical company focused on women's health. It develops products for contraception, the treatment of infections, and other conditions. This market has historically been underserved but has enormous potential. Dare's success depends on clinical data and the potential to address significant unmet needs among women.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company DARE
Dare Bioscience is a biopharmaceutical company focused exclusively on developing women's health products. Its future sales forecast reflects the expected commercial success of its diverse pipeline of candidates targeting areas such as contraception and vaginal health.
%20sales%20of%20the%20company%20DARE&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-DARE&v=1772582747058 "Schedule of future (projected) sales of the company DARE")
Future (projected) sales of companies in the market segment - Pharma women
Dare Bioscience is a biopharmaceutical company focused on developing innovative products for women's health. This chart shows expectations for the entire women's pharmaceutical sector. It helps assess analysts' forecasts for demand for new contraceptive methods and treatments for women's conditions, which determines market potential.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20women&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-women&v=1772582747167 "Schedule of future (projected) sales of companies in the market segment - Pharma women")
Future (projected) sales of the market as a whole
Dare Bioscience specializes in women's health. The company's success depends on the approval of its drugs and the healthcare system's willingness to pay for innovation in this area. This chart of overall sales forecasts reflects the overall economic situation affecting healthcare budgets.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772582747275 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality DARE
Dare Bioscience, Inc. is a biopharmaceutical company focused exclusively on developing women's health products. This chart reflects its financial performance at the clinical stage, where high R&D expenditures are an investment in building a portfolio of innovative products to address unmet medical needs for women.
Market segment marginality - Pharma women
Dare Bioscience is a biopharmaceutical company focused exclusively on women's health. This narrow focus can provide an advantage in market understanding, but requires effective R&D. The chart shows how profitable their business model is compared to more diversified pharmaceutical companies.
Market marginality as a whole
Dare Bioscience, Inc. is a biopharmaceutical company focused exclusively on women's health. It develops new treatments in areas such as contraception and vaginal infections. This chart shows overall profitability, but for DARE, its ability to address the unique and unmet medical needs of women determines its market potential.
Employees in the company, segment and market as a whole
Number of employees in the company DARE
Daré Bioscience is a biotech company focused entirely on women's health. This chart shows a compact team managing the development and clinical trials of a portfolio of innovative products. The small staff is typical of a model where many functions are outsourced.
Share of the company's employees DARE within the market segment - Pharma women
Daré Bioscience is a biopharmaceutical company focused exclusively on women's health, a historically underfunded area with significant needs. This metric reflects its important role as an employer of scientists working to develop new therapeutic solutions for women.
Number of employees in the market segment - Pharma women
Dare Bioscience is a biopharmaceutical company focused on developing women's health products. This chart shows employment in this sector. The growing number of researchers and clinicians in this field indicates a growing recognition of unmet needs in women's health and increased investment in this important area.
Number of employees in the market as a whole
Dare Bioscience focuses on women's health. Demand for products in this area is driven by demographic and medical needs, not the state of the economy. This chart shows general trends, but for Dare, offering effective solutions to improve women's quality of life is more important.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company DARE (DARE)
Daré Bioscience, Inc. is a biopharmaceutical company focused on women's health. The high market capitalization per employee in this chart is typical for a development-stage company. The market evaluates the potential of its unique products to solve important medical problems, not the size of its staff.
%20of%20the%20company%20DARE%20(DARE)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-DARE-DARE&v=1772582747791 "Chart of market capitalization per employee (in thousands of dollars) of the company DARE (DARE)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma women
Dare Bioscience, Inc. is a biopharmaceutical company focused on developing innovative products for women's health. In this niche pharmaceutical field, the cost per employee reflects the market valuation of their development pipeline, indicating investors' confidence in the commercial potential of their products.
%20by%20market%20segment%20-%20Pharma%20women&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-women&v=1772582747808 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma women")
Market capitalization per employee (in thousands of dollars) for the overall market
Dare Bioscience, Inc. is a biopharmaceutical company focused exclusively on developing products for women's health. The chart shows how the market values their portfolio of drugs in this important, yet often overlooked, area of medicine.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772582747832 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company DARE (DARE)
Dare Bioscience (DARE) is a biopharmaceutical company focused exclusively on women's health. They develop products for contraception, vaginal health, and sexual function. This graph (negative) shows R&D intensity. It measures how much capital is "burned" per scientist to develop and approve products in this underserved but important area of medicine.
%20Chart%20DARE%20(DARE)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-DARE-DARE&v=1772582747943 "Company Profit Per Employee (in thousands of dollars) Chart DARE (DARE)")
Profit per employee (in thousands of dollars) in the market segment - Pharma women
Daré Bioscience is a biopharmaceutical company focused on developing innovative products for women's health. In this niche field, R&D efficiency and speed to market are critical. This chart shows the value created by their scientific team and serves as a benchmark against other companies in the women's health sector.
%20in%20the%20market%20segment%20-%20Pharma%20women&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-women&v=1772582747962 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma women")
Profit per employee (in thousands of dollars) for the market as a whole
Dare Bioscience (DARE) is a biotech company focused on women's health. The company is in the R&D stage. Negative profit per employee is the norm. The graph shows the "cost" of a team of scientists and doctors developing new treatments without yet having commercial products.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772582748050 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee DARE (DARE)
Daré Bioscience is a biopharmaceutical company focused on women's health. Being in the clinical stage, its revenue may be minimal. This timeline will indicate whether the company can successfully commercialize its innovative products for women.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-DARE-DARE&v=1772582748130 "Sales chart per company employee DARE (DARE)")
Sales per employee in the market segment - Pharma women
Dare Bioscience is a biopharmaceutical company focused exclusively on women's health. They develop new treatments for vaginal infections, contraception, and more. This chart compares Dare's revenue per employee to the industry average. This demonstrates how productive their niche R&D portfolio is.
Sales per employee for the market as a whole
Dare Bioscience (DARE) is a biotech company focused exclusively on women's health (contraception, vaginal infections). They have one approved product. This chart shows how efficiently their small team generates revenue from this product (and partnerships) per employee.
Short shares by company, segment and market as a whole
Shares shorted by company DARE (DARE)
Dare Bioscience (DARE) is a biopharmaceutical company focused exclusively on women's health (contraception, infections). This is an important but historically underfunded market. This chart shows the number of investors who doubt the commercial potential of the company's products or its chances of FDA approval.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-DARE-DARE&v=1772582748316 "Short Shares Chart for the Company DARE (DARE)")
Shares shorted by market segment - Pharma women
Dare Bioscience (DARE) is a biopharmaceutical company focused exclusively on women's health. They develop contraceptives, anti-infective medications, and sexual health treatments. This chart shows the odds against the "women's health" sector, reflecting market skepticism that this niche area receives sufficient attention and funding.
Shares shorted by the overall market
Dare Bioscience focuses exclusively on women's health, developing treatments for infections and contraception. This is a niche but important segment of biotech. This chart illustrates the general market fear. When investors are afraid, they don't want to wait for FDA approvals. They sell off DARE shares, fearing the company won't be able to raise capital to complete trials amid market panic.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator DARE (DARE)
Daré Bioscience (DARE) is focused exclusively on developing women's health products—an often undervalued but important niche. Shares react to news of clinical trials. This chart measures the rate of price change. It helps identify when positive expectations (above 70) or disappointment (below 30) peak, which could indicate an imminent correction or rebound.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-DARE-DARE&v=1772582748523 "RSI 14 indicator chart for the company's stock DARE (DARE)")
RSI 14 Market Segment - Pharma women
Dare Bioscience (DARE) is a biotech company focused exclusively on women's health. They are developing a portfolio of drugs ranging from contraception to infection treatments. This chart gauges the overall sentiment in the women's health sector. It helps understand whether DARE's performance reflects their developments or whether this important sector is overheated or oversold.
RSI 14 for the overall market
Dare Bioscience (DARE) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast DARE (DARE)
Daré Bioscience (DARE) is a biopharmaceutical company focused exclusively on women's health. Its portfolio includes the approved Xaciato (bacterial vaginosis) and contraceptives. This chart shows the average price target from analysts assessing the commercial launch of Xaciato and the success of its R&D portfolio.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-DARE-DARE&v=1772582748656 "A chart showing analyst consensus forecasts for the expected stock price. DARE (DARE)")
The difference between the consensus estimate and the actual stock price DARE (DARE)
Dare Bioscience is a biopharmaceutical company with a unique focus on women's health. Their R&D portfolio includes contraceptives, gels, and anti-infective drugs. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their belief in this "women's" R&D portfolio.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-DARE-DARE&v=1772582748664 "A chart showing the difference between the consensus forecast and the actual stock price. DARE (DARE)")
Analyst consensus forecast for stock prices by market segment - Pharma women
Daré Bioscience (DARE) is a biopharmaceutical company focused exclusively on women's health. It develops new methods for contraception and treatment of infections and vaginosis. This chart shows general expectations for the pharmaceutical sector. It reflects whether experts believe in the growth of this historically underfunded R&D sector.
Analysts' consensus forecast for the overall market share price
Dare Bioscience (DARE) is a biopharmaceutical company focused exclusively on women's health. They are developing a broad portfolio (contraceptives, infections) to fill this gap. This chart shows the overall risk appetite. It reflects the willingness of investors to fund R&D projects in "non-hyped" but important areas of medicine.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index DARE
Dare Bioscience is an R&D company focused exclusively on women's health. Their specialty isn't R&D from scratch, but rather smart discovery: they license (acquire) promising but neglected drugs (for contraception, infections) and bring them to FDA approval. This chart is a summary indicator of their R&D portfolio strategy. It reflects their progress in clinical trials and their ability to find a winner.
AKIMA Market Segment Index - Pharma women
Daré Bioscience (DARE) is a biopharmaceutical company focused exclusively on women's health. They are developing a portfolio of innovative products, ranging from contraceptives to treatments for vaginal infections. The chart shows the average index for the segment, helping investors assess how this women-focused approach compares to the industry average.
The AKIM Index for the overall market
Daré Bioscience is a biopharmaceutical company focused exclusively on women's health (contraception, fertility, and sexual health). This chart, which reflects the market average, provides a macro backdrop. It helps assess how Daré, which is developing a portfolio of innovative products, compares to overall economic trends.
